Propionic Acid

Propionic Acid

SCHEMBL4157631

CCC(=O)O.Cc1ccc(NS(=O)(=O)c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)cc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 2/20 0.54
MAPT P10636 6/20 0.49
TP53 P04637 5/20 0.49
LMNA P02545 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
PKM P14618 4/20 0.47
GAA P10253 1/20 0.47
AR P10275 1/20 0.47
POLB P06746 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PDE3A Q14432 1/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ESR1 P03372 1/20 0.43
CYP19A1 P11511 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4155591 0.94 BRD4 (0.50) BRAFMAPTTP53LMNAMEN1
Propionic Acid SCHEMBL4153953 0.92 PKM (0.55) BRAFMAPTTP53LMNAMEN1
Propionic Acid SCHEMBL4163285 0.92 PKM (0.54) BRAFMAPTTP53LMNAPKM
Propionic Acid SCHEMBL4160232 0.91 BRD4 (0.51) BRAFMAPTTP53LMNAPKM
Propionic Acid SCHEMBL4161141 0.91 BRAF (0.53) BRAFMAPTTP53LMNAMEN1
Propionic Acid SCHEMBL4162959 0.91 BRAF (0.46) BRAFMAPTTP53LMNAKMT2A
Propionic Acid SCHEMBL4163726 0.90 BRD4 (0.54) MAPTTP53LMNAMEN1KMT2A
Propionic Acid SCHEMBL4162436 0.90 MAPT (0.52) BRAFMAPTTP53LMNAMEN1
Propionic Acid SCHEMBL4158062 0.89 MEN1 (0.60) MAPTTP53LMNAMEN1KMT2A
Propionic Acid SCHEMBL4166797 0.88 PKM (0.43) BRAFMAPTTP53LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 BRAF 38/4885MAPT 734/4885TP53 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.